血清甲索特水平预测高剂量甲索特后的急性损伤:一个病例报告和单一中心的经验
Pao-Wen Yen1, Hsing-Yu Lin2, Chien-Chih Wu2
1Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
International journal of nephrology and renovascular disease
|November 11, 2024
概括
高剂量的甲状腺素 (HD-MTX) 可以导致急性损伤 (AKI). 早期监测血清甲状腺酸盐水平对于预防AKI至关重要,并为修改的HD-MTX协议提供信息.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性损伤 (AKI) 是高剂量甲状腺酸盐 (HD-MTX) 化疗的显著并发症.
- 对于HD-MTX诱导的AKI而言,已有的预防措施并不总是足够的.
- 这项研究调查了AKI的风险因素,并提出了协议修改.
研究的目的:
- 在接受HD-MTX的患者中确定AKI的危险因素.
- 建议修改HD-MTX治疗方案,以减少AKI发生率.
- 评估血清甲状腺素水平对AKI的预测意义.
主要方法:
- 在HD-MTX治疗后发生严重AKI的病例报告.
- 对70名接受HD-MTX治疗的患者进行了回顾性审查.
- 分析血清甲状腺素水平,以预测AKI的发展.
主要成果:
- 该病例患者经历了甲醇中毒和严重的AKI,需要进行血液透析.
- 血清甲托雷克萨特水平是AKI的显著预测因素 (OR 11.84,p=0.001).
- 较高的初始血清甲铁酸水平与增加的AKI风险相关.
结论:
- 及时监测血清甲醇水平对于管理和预防HD-MTX诱导的AKI至关重要.
- 建议修改HD-MTX协议,以更早的监测和调整的支持性护理.
- 拟议的协议旨在降低接受HD-MTX治疗的患者中AKI的发生率.
更多相关视频
07:11A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
1.4K
06:48Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
Published on: April 29, 2022
2.2K
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
57
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
57
01:11Renal Failure: Dose Adjustments
67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67